1 paper
Ethan M. Alt, Matthew A. Psioda, Joseph G. Ibrahim
Given the cost and duration of phase III and phase IV clinical trials, the development of statistical methods for go/no-go decisions is vital. In this paper, we introduce a Bayesia…